Skip to main content

Let's KINNECT!

"*" indicates required fields

October 12, 2026 | In The Media

Key Person Life Insurance: Protecting Business Value Before an Exit

A company may own equipment, contracts, and intellectual property, yet much of its earning power can depend on one founder, executive, rainmaker, or technical leader. Key person life insurance covers an essential individual, with the business paying premiums and serving as policy owner and beneficiary. If that person dies while coverage is active, the benefit gives the organization capital during a transition.

For owners considering a sale, the policy addresses a risk buyers, lenders, and investors may examine: what happens if a central contributor is suddenly unavailable?

Why One Person Can Affect Enterprise Value

Business value commonly reflects expected earnings, transferable operations, customer retention, leadership depth, and perceived risk. When one individual controls major client relationships, holds unique operating knowledge, or drives a large share of revenue, that dependence may make future cash flow appear less reliable. A buyer may respond with a lower valuation, deferred payments, or conditions tied to that person’s continued service.

A financial advisor can help quantify the economic contribution at risk and coordinate the analysis with valuation, tax, legal, and transaction professionals. The review may consider lost revenue, replacement compensation, recruiting costs, debt, and the time needed for a successor to become productive. The goal is to estimate the financial strain the company could face.

How Coverage Supports Continuity

The National Association of Insurance Commissioners defines key-person insurance as coverage purchased by and for the benefit of a business on personnel integral to its operations. The NAIC also recommends considering it early, because later health changes may increase the cost or limit availability.

The benefits available through business life insurance may provide liquidity to recruit leadership, retain employees, reassure creditors, replace profit, or fund obligations while management determines the next step. It does not make the company independent of that person. Buyers will still assess documented procedures, delegated authority, customer concentration, employment agreements, and management depth.

Connecting the Policy to an Exit

Insurance works best when it supports exit planning rather than sitting apart from the transaction plan. Owners should review the insured person, benefit amount, policy term, ownership, beneficiary designation, and any cash value well before marketing the company. A term policy may address a defined transition period, while permanent coverage may fit a longer need. Product choice should follow the company’s purpose, time horizon, budget, and exit assumptions.

The policy should also be coordinated with buy-sell agreements, lender requirements, executive compensation, and the intended sale structure. A financial advisor can help bring insurance into a wider plan involving business, wealth, retirement, and legacy objectives. That integration matters when sale proceeds will fund the owner’s next phase or support multiple generations.

Reviewing Amounts and Ownership Before a Sale

Coverage based only on a convenient multiple may miss the exposure. A needs-based calculation can account for the executive’s contribution to profit, the cost and duration of replacement, outstanding loans, transition expenses, and revenue that could be lost. The amount should be reviewed as the company grows, leadership roles change, or the projected exit date moves.

Good business succession planning also asks whether the organization can function without the insured individual. Written procedures, cross-trained leaders, diversified customer relationships, and clear authority can reduce dependence over time. Insurance supplies funds after a covered death; operational preparation helps preserve performance before and during a transfer. Together, they can present a more durable company to potential buyers.

Tax and Transaction Details Require Attention

Federal tax treatment should never be assumed. The IRS states that life insurance death benefits are generally excluded from a beneficiary’s gross income, although exceptions and separate treatment for interest or transferred policies may apply. Employer-owned contracts can also carry notice, consent, and reporting requirements, including IRS Form 8925. Owners should obtain tax and legal advice for their particular structure before buying, transferring, or terminating a policy.

During a sale, the parties must decide whether the policy stays with the company, transfers subject to applicable rules, or ends before closing. That decision may affect purchase documents, pricing, consent requirements, and tax results. Early review leaves time to correct outdated ownership or beneficiary records without delaying due diligence.

Make the Business Less Dependent on Chance

An exit plan is stronger when it accounts for the people who produce the company’s value as carefully as it accounts for revenue and assets. KINNECT Financial serves business owners in Florida and throughout the United States, aligning coverage with succession, transaction, and personal wealth goals. To assess key-person exposure before a buyer raises the issue, contact us today and begin building a plan around the company you intend to transfer.

This material is for informational and educational purposes only and is not intended as individualized investment, legal, or tax advice. Financial strategies, including those related to healthcare planning and long‑term care, are based on general assumptions and may not be suitable for every individual.

Securities and investment advisory services off ered through qualified registered representatives of MML Investors Services, LLC. Member SIPC. https://www.sipc.org/ Kinnect Financial is not a subsidiary or affi liate of MML Investors Services, LLC, or its affi liated companies. 1000 Corporate Drive Suite 700 Fort Lauderdale, FL 33334 (954) 558-8333

CRN202909-12091875